201 related articles for article (PubMed ID: 12636872)
21. Urinary angiotensin I-converting enzyme activity is increased in experimental acute renal failure.
Pedraza-Chaverrí J; Moreno-Muñiz SI; Cruz C; Hernández-Pando R; Larriva-Sahd J; Tapia E
Clin Invest Med; 1995 Dec; 18(6):424-34. PubMed ID: 8714786
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
Benigni A; Gagliardini E; Remuzzi A; Corna D; Remuzzi G
Am J Pathol; 2001 Nov; 159(5):1743-50. PubMed ID: 11696435
[TBL] [Abstract][Full Text] [Related]
23. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
24. Effect of ACE inhibition on glomerular permselectivity and tubular albumin concentration in the renal ablation model.
Sangalli F; Carrara F; Gaspari F; Corna D; Zoja C; Botti L; Remuzzi G; Remuzzi A
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1291-300. PubMed ID: 21454255
[TBL] [Abstract][Full Text] [Related]
25. Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Wapstra FH; Navis G; DE Jong PE; DE Zeeuw D
J Am Soc Nephrol; 2000 Mar; 11(3):490-496. PubMed ID: 10703672
[TBL] [Abstract][Full Text] [Related]
26. ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy.
Wapstra FH; Navis GJ; van Goor H; van den Born J; Berden JH; de Jong PE; de Zeeuw D
Exp Nephrol; 2001; 9(1):21-7. PubMed ID: 11053977
[TBL] [Abstract][Full Text] [Related]
27. Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.
Windt WA; Tahara A; Kluppel AC; de Zeeuw D; Henning RH; van Dokkum RP
J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):217-24. PubMed ID: 17347933
[TBL] [Abstract][Full Text] [Related]
28. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
Gansevoort RT; Heeg JE; Dikkeschei FD; de Zeeuw D; de Jong PE; Dullaart RP
Nephrol Dial Transplant; 1994; 9(3):244-50. PubMed ID: 8052429
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
30. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
Med Sci Monit; 2002 Feb; 8(2):BR69-74. PubMed ID: 11859270
[TBL] [Abstract][Full Text] [Related]
31. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
Matsuda H; Hayashi K; Saruta T
J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
[TBL] [Abstract][Full Text] [Related]
32. Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric rats.
Deelman LE; Navis G; de Boer E; Wietses M; de Zeeuw D; Henning RH
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):38-42. PubMed ID: 12692752
[TBL] [Abstract][Full Text] [Related]
33. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis.
Kramer AB; van der Meulen EF; Hamming I; van Goor H; Navis G
Kidney Int; 2007 Mar; 71(5):417-24. PubMed ID: 17213874
[TBL] [Abstract][Full Text] [Related]
34. Low sodium modifies the vascular effects of angiotensin-converting enzyme inhibitor therapy in healthy rats.
Kocks MJ; Gschwend S; de Zeeuw D; Navis G; Buikema H
J Pharmacol Exp Ther; 2004 Sep; 310(3):1183-9. PubMed ID: 15175418
[TBL] [Abstract][Full Text] [Related]
35. Proximal renal tubular peptide catabolism, ammonia excretion and tubular injury in patients with proteinuria: before and after lisinopril.
Rustom R; Grime JS; Costigan M; Maltby P; Hughes A; Shenkin A; Critchley M; Bone JM
Clin Sci (Lond); 1998 Apr; 94(4):425-30. PubMed ID: 9640348
[TBL] [Abstract][Full Text] [Related]
36. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome.
Eddy AA; McCulloch L; Liu E; Adams J
Am J Pathol; 1991 May; 138(5):1111-23. PubMed ID: 2024704
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the effects of converting-enzyme inhibition and protein restriction in experimental nephrosis.
Beukers JJ; Hoedemaeker PJ; Weening JJ
Lab Invest; 1988 Nov; 59(5):631-40. PubMed ID: 3054313
[TBL] [Abstract][Full Text] [Related]
38. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
Guron G
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
[TBL] [Abstract][Full Text] [Related]
39. Acute renal failure during lisinopril and losartan therapy for proteinuria.
Hanevold CD
Pharmacotherapy; 2006 Sep; 26(9):1348-51. PubMed ID: 16945058
[TBL] [Abstract][Full Text] [Related]
40. Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?
Bos H; Henning RH; De Jong PE; De Zeeuw D; Navis G
Nephrol Dial Transplant; 2002 May; 17(5):793-7. PubMed ID: 11981065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
